MYCN and neuroblastoma: To evaluate the immunogenic changes occurring upon treatment with PBNP-PTT at varied thermal doses across neuroblastoma cell lines with different MYCN amplification statuses, we compared the effects of thermal dose on SH-SY5Y cells versus LAN-1 cells.